BRCA1 Promoter Hypermethylation Signature for Early Detection of Breast Cancer in the Vietnamese Population |
Truong, Phuong Kim
(Department of Biotechnology Applications in Medicine, Faculty of Biotechnology, Ho Chi Minh City Medicine and Pharmacy University)
Lao, Thuan Duc (Department of Biotechnology Applications in Medicine, Faculty of Biotechnology, Ho Chi Minh City Medicine and Pharmacy University) Doan, Thao Phuong Thi (Department of Pathological Anatomy, Faculty of Medicine) Huyen, Thuy Ai (Department of Biotechnology Applications in Medicine, Faculty of Biotechnology, Ho Chi Minh City Medicine and Pharmacy University) |
1 | Alsner J, Yilmaz M, Guldberg P, Hansen LL, Overgaard J (2000). Heterogeneity in the clinical phenotype of TP53 mutations in breast cancer patients. Clin Cancer Res, 6, 3923-31. |
2 | Birgisdottir V, Stefansson OA, Bodvarsdottir SK, et al (2006). Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer. Breast Cancer Res, 8, 38. |
3 | Chomczynski P, Sacchi N (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal Biochem, 162, 156-9. |
4 | Dulaimi E, Hillinck J, Ibanez de Caceres I, Al-Saleem T, Cairns P (2004). Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients. Clin Cancer Res, 10, 6189-93. DOI ScienceOn |
5 | Esteller M, Corn PG, Baylin SB, Herman JG (2001). A gene hypermethylation profile of human cancer. Cancer Res, 61, 3225-9. |
6 | Evron E, Umbricht CB, Korz D, et al (2001). Loss of cyclin D2 expression in the majority of breast cancers is associated with promoter hypermethylation. Cancer Res, 61, 2782-7. |
7 | Fang WJ, Zheng Y, Wu LM, et al (2012). Genome-wide analysis of aberrant DNA methylation for identification of potential biomarkers in colorectal cancer patients. Asian Pac J Cancer Prev, 13, 1917-21. 과학기술학회마을 DOI ScienceOn |
8 | Hedenfalk I, Duggan D, Chen Y, et al (2001). Gene-expression profiles in hereditary breast cancer. N Engl J Med, 344, 539-48. DOI ScienceOn |
9 | Hoang Lan N, Laohasiriwong W, Stewart JF, Tung ND, Coyte PC (2013). Cost of treatment for breast cancer in central Vietnam. Glob Health Action, 6, 18872-81. |
10 | Hsu NC, Huang YF, Yokoyama KK, et al (2013). Methylation of BRCA1 promoter region is associated with unfavorable prognosis in women with early-stage breast cancer. PLoS One, 8, 56256. DOI |
11 | Ibanez de Caceres I, Battagli C, Esteller M, et al. (2004) Tumor cell-specific BRCA1 and RASSF1A hypermethylation in serum, plasma, and peritoneal fluid from ovarian cancer patients. Cancer Res, 64, 6476-81. DOI ScienceOn |
12 | Jacot W, Thezenas S, Senal R, et al (2013). BRCA1 promoter hypermethylation, 53BP1 protein expression and PARP-1 activity as biomarkers of DNA repair deficit in breast cancer. BMC Cancer, 13, 523. DOI |
13 | Kulis M, Esteller M (2010). DNA methylation and cancer. Adv Genet, 70, 27-56. DOI |
14 | Pongtheerat T, Pakdeethai S, Purisa W, Chariyalertsak S, Petmitr S (2011). Promoter methylation and genetic polymorphism of glutathione S-transferase P1 gene (GSTP1) in Thai breastcancer patients. Asian Pac J Cancer Prev, 12, 2731-4. |
15 | Ramezani F, Salami S, Omrani MD, Maleki D (2012). CpG island methylation profile of estrogen receptor alpha in Iranian females with triple negative or non-triple negative breast cancer: new marker of poor prognosis. Asian Pac J Cancer Prev, 13, 451-7. 과학기술학회마을 DOI ScienceOn |
16 | Tapia T, Smalley SV, Kohen P, et al (2008). Promoter hypermethylation of BRCA1 correlates with absence of expression in hereditary breast cancer tumors. Epigenetics, 3, 157-63. DOI |
17 | Xu X, Gammon MD, Zhang Y, et al (2009). BRCA1 promoter methylation is associated with increased mortality among women with breast cancer. Breast Cancer Res Treat, 115, 397-404. DOI |
18 | Terada K, Okochi-Takada E, Akashi-Tanaka S, et al (2009). Association between frequent CpG island methylation and HER2 amplification in human breast cancers. Carcinogenesis, 30, 466-71. DOI |